A phase II trial of sorafenib (SO) in advanced chordoma patients (pt). This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This abstract does not include a full text component.
Qualitative data captures information and concepts that cannot be easily described by numbers, to better understand a phenomenon of interest from different perspectives. This data may include people's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results